32 LUX-Lung 3: Symptom and health-related quality of life results from a randomized phase III study in 1st-line advanced NSCLC patients harbouring EGFR mutations

✍ Scribed by O'Byrne, K.J.; Sequist, L.V.; Schuler, M.; Yamamoto, N.; Hirsh, V.; Mok, T.; Lungershausen, J.; Shahidi, M.; Palmer, M.; Yang, J.C.-H.

• Book ID: 122860439
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 45 KB
• Volume: 79
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/S0169-5002(13)70032-1